These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1968828

  • 1. Conditions for maximizing and inhibiting synthesis of glutathione in cultured rat lenses: an application of HPLC with radioisotope detection.
    Murray DL, Rathbun WB.
    Curr Eye Res; 1990 Jan; 9(1):55-63. PubMed ID: 1968828
    [Abstract] [Full Text] [Related]

  • 2. Age-related cysteine uptake as rate-limiting in glutathione synthesis and glutathione half-life in the cultured human lens.
    Rathbun WB, Murray DL.
    Exp Eye Res; 1991 Aug; 53(2):205-12. PubMed ID: 1915676
    [Abstract] [Full Text] [Related]

  • 3. Cysteine and glutathione metabolism in organ-cultured rat corneas.
    Li J, Rathbun WB, Murray DL.
    Curr Eye Res; 1990 Sep; 9(9):883-91. PubMed ID: 2245648
    [Abstract] [Full Text] [Related]

  • 4. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB, Hayward ML, Griffith OW.
    Anal Biochem; 1991 May 01; 194(2):268-77. PubMed ID: 1677799
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of 2-mercaptoethanol and buthionine sulfoximine on cystine metabolism by and proliferation of mitogen-stimulated human and mouse lymphocytes.
    Messina JP, Lawrence DA.
    Int J Immunopharmacol; 1992 Oct 01; 14(7):1221-34. PubMed ID: 1452407
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells.
    Noda T, Iwakiri R, Fujimoto K, Rhoads CA, Aw TY.
    Cell Prolif; 2002 Apr 01; 35(2):117-29. PubMed ID: 11952646
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cystine/glutamate antiporter expression in retinal Müller glial cells: implications for DL-alpha-aminoadipate toxicity.
    Kato S, Ishita S, Sugawara K, Mawatari K.
    Neuroscience; 1993 Nov 01; 57(2):473-82. PubMed ID: 7906874
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine.
    Malaker K, Hurwitz SJ, Bump EA, Griffith OW, Lai LL, Riese N, Coleman CN.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):407-12. PubMed ID: 7910818
    [Abstract] [Full Text] [Related]

  • 16. Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells.
    Gout PW, Kang YJ, Buckley DJ, Bruchovsky N, Buckley AR.
    Leukemia; 1997 Aug 15; 11(8):1329-37. PubMed ID: 9264389
    [Abstract] [Full Text] [Related]

  • 17. Plasma glutathione turnover in the rat: effect of fasting and buthionine sulfoximine.
    Hum S, Robitaille L, Hoffer LJ.
    Can J Physiol Pharmacol; 1991 May 15; 69(5):581-7. PubMed ID: 1863907
    [Abstract] [Full Text] [Related]

  • 18. Glutathione biosynthesis and its inhibition.
    Meister A.
    Methods Enzymol; 1995 May 15; 252():26-30. PubMed ID: 7476360
    [No Abstract] [Full Text] [Related]

  • 19. Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
    Le CT, Hollaar L, van der Valk EJ, van der Laarse A.
    J Mol Cell Cardiol; 1993 May 15; 25(5):519-28. PubMed ID: 8104252
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.